I beleive based on the AP article i read this morning that Abbott is still the owner of the technology. Abbott is retaining the molecular division which has cancer detection as one of the primary concerns. Things take time, especially in the medical community, be patient you will be rewarded in my opinion.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.